Biotechnology Sector

In recent years, the demand for sustainable practices in biotechnology has gained significant momentum, particularly in the realm of biomaterials and bioproduction processes. A groundbreaking study conducted by Almeida et al. aims to address these issues by exploring the circular valorisation of essential oil post-distillation by-products. As the global essential oil market continues to thrive,

Groundwater is often heralded as a crucial resource in agricultural ecosystems, sustaining both crop production and drinking water supplies. However, recent research highlights a troubling trend in this essential water source: pesticide contamination. In their comprehensive study, Acharya, Paramaguru, and Tripathi explore the multifaceted processes that lead to pesticide pollution in groundwater, examining the resulting

In a groundbreaking study published in the Journal of Cancer Research and Clinical Oncology, researchers have unveiled a novel mechanism by which the FBXW11 protein exerts anti-tumor effects in hepatocarcinoma, a deadly form of liver cancer. The study, led by Liu, W., Xu, B., Wang, T., and colleagues, highlights the role of FBXW11 in the

Recent advancements in biotechnology and artificial intelligence have led to significant breakthroughs in drug development, particularly in the realm of anticancer therapeutics. Among these advancements, the research conducted by Lv, Li, and Wang introduces a novel framework named ACP-EPC, which effectively leverages a pre-trained protein language model alongside a multi-view feature extracting strategy. This unprecedented

In a groundbreaking exploration of the intersection between psychological disorders, a recent case study sheds light on the intricate therapeutic processes involved in treating patients battling both Anorexia Nervosa (AN) and Complex Post-Traumatic Stress Disorder (C-PTSD). The study chronicles the experiences of an out-patient individual whose treatment journey unfolds under the skilled guidance of mental

In a breakthrough study led by Mohan and colleagues, researchers have synthesized silver-zinc oxide nanocomposites derived from turmeric (Curcuma longa) that exhibit promising antimicrobial and photocatalytic properties. This innovative approach not only highlights the incredible versatility of natural biopolymers but also provides a sustainable method for managing environmental pollutants and combatting multi-drug-resistant pathogens, which pose

In a groundbreaking multicenter study encompassing 4,801 patients, researchers have unveiled critical insights into how preoperative body mass index (BMI) influences postoperative outcomes in individuals undergoing cardiac surgery for infective endocarditis (IE). This pioneering work, recently published in the International Journal of Obesity, addresses a relatively unexplored territory in cardiovascular infectious disease—the interplay between body

In the evolving landscape of hepatocellular carcinoma (HCC), a primary liver cancer type, there is a growing urgency to integrate precision medicine into the protocols governing liver transplantation. A recent study by Tian, Wang, and Lu highlights the transformative potential of third-generation sequencing technology in enhancing patient selection, treatment strategies, and post-transplant outcomes. This research

In a groundbreaking study set to redefine the understanding of sports equipment, a team of researchers including Phillips, Harland, and Mitchell delves into the characteristics and mechanisms of static water uptake in both leather and synthetic association footballs. This research, published in the journal Sports Engineering, sheds light on an often-overlooked aspect of football performance

In an innovative approach to sustainable infrastructure, a groundbreaking study has illuminated a unique opportunity inherent in agricultural waste. The study, conducted by Zhang et al., investigates the potential of repurposing grape and olive pomaces—by-products of the wine and olive oil industries—into bio-renewable antioxidants that can enhance the quality and longevity of asphalt paving materials.

In a groundbreaking study, researchers have highlighted the innovative application of quicklime in enhancing nutrient recovery during the co-composting process of sewage sludge mixed with municipal solid waste. This sustainable approach is becoming increasingly vital as urban areas grapple with effective waste management solutions amid growing environmental concerns. The mission to convert organic waste into

The landscape of epilepsy management is evolving, and researchers are continually seeking to uncover more effective treatments to enhance patient outcomes. A recent study led by Usui et al. sheds light on the management of focal-onset seizures—particularly those experienced by adult Asian patients undergoing adjunctive therapy with the antiseizure medication brivaracetam. This research offers invaluable

In a groundbreaking study that pushes the boundaries of cancer research, scientists have unveiled new insights into how the tumor microenvironment (TME) in breast cancer responds to neoadjuvant therapy. Utilizing state-of-the-art single-cell and spatial omics technologies, researchers have successfully mapped the complex cellular ecosystem that surrounds and influences breast tumors during treatment, revealing dynamic interactions

In the constantly evolving world of natural product research, the exploration of unconventional plant oils has garnered significant scientific attention. A groundbreaking study recently published in Food Science and Biotechnology shines a spotlight on Idesia polycarpa fruit oil, delving into how various extraction methods influence its chemical profile, aroma compounds, and antioxidant potency. This comprehensive

In the relentless pursuit of effective cancer therapies, researchers have turned an increasingly keen eye toward the mechanisms by which tumors evade the immune system. A groundbreaking study has recently brought to light innovative strategies centered around PD-L1 siRNA, a cutting-edge tool aimed at dismantling the defenses employed by malignant cells within the immune landscape.

Avoidant Restrictive Food Intake Disorder (ARFID) is an increasingly recognized condition that affects individuals, particularly children. Recent advancements in research have shed light on this disorder, specifically targeting its prevalence in Swedish preschool populations. This specific demographic has gained attention as caregivers and health professionals strive to uncover the intricacies of ARFID and manage its

In the intricate and relentless quest to overcome cancer resistance to chemotherapy, a fascinating new frontier has emerged that delves deep into the cellular and molecular underpinnings of tumor biology. Recent systematic analyses highlight the pivotal role played by non-coding RNAs (ncRNAs) in modulating the sensitivity of cancer cells to Topotecan, a widely used chemotherapeutic

A groundbreaking study has emerged from the field of pediatric radiology, challenging long-held assumptions about the timing of intervention in cases of ileocolic intussusception. Traditional guidelines have emphasized the urgency of timely treatment following the diagnosis of this significant gastrointestinal condition, which primarily affects children. However, research conducted by Gonzalo Cruz and Ben L. Graeber

In recent years, the aquaculture industry has witnessed significant advancements in both breeding and transportation methodologies. Among the various species cultivated, Rohu (Labeo rohita) has emerged as a cornerstone of freshwater aquaculture in South Asia. The focus on Rohu is not only due to its economic viability but also its nutritional value and adaptability to

In the realm of analytical chemistry, the detection and quantification of gaseous hydrogen peroxide (H2O2) have become increasingly significant due to its applications across various fields such as environmental monitoring, food safety, and healthcare. Recent advancements in sensing technologies have paved the way for the development of innovative catalytic systems that are both efficient and

AstraZeneca has paused a 200 million pound sterling (about $271 million) investment in its Cambridge, England, research site, the latest Big Pharma to pull back from the U.K. this week, a company spokesperson has confirmed to Fierce Biotech.

Check out eight important biotechnology careers that are currently in high demand, and likely still will be in the coming years. The post Eight biotech career paths where demand is skyrocketing appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Eli Lilly is reconsidering plans for its U.K. biotech-focused Gateway Labs amid concerns about the industry’s outlook in the country and low government spend on drug development, according to reports from several outlets.

Maryland-based biotech Galimedix Therapeutics is ready to take a big swing on its oral Alzheimer’s disease candidate after the small molecule caused no serious adverse events and successfully crossed the blood-brain barrier in a phase 1 trial.

Our guest today is Mati Gill, CEO of AION Labs. AION Labs has an innovative company creation process that empowers startups to tackle high-impact challenges with AI, backed by top-tier data, funding, and expertise. The post AION Labs is building innovative biotechs with top pharma partners in Israel appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

With its head of U.S. business Julie Kim sliding up to the CEO spot next June, Takeda has locked in a replacement in Rhona Pacheco. Pacheco is set to leave behind her role as Eli Lilly’s VP of U.S. cardiometabolic health, the most recent title she’s held along her 20-year tenure at Lilly which saw her overseeing the company’s booming GLP-1 drug portfolio.

Arrowhead Pharmaceuticals has launched legal action against Ionis Pharmaceuticals, aiming to neutralize Ionis' claim that Arrowhead's potential rival to Tryngolza breaches a patent.

FibroGen has agreed to pay $1.25 million to the Securities and Exchange Commission to address allegations that its former chief medical officer manipulated data for the anemia drug roxadustat.

Capsida Biotherapeutics has paused a gene therapy clinical trial after the first patient died. The biotech, which began the phase 1/2 study in July, took the action to give it time to determine the root cause of the death.

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning.

Less than two years after breaking ground on a ballyhooed 1 billion pound sterling ($1.31 billion) R&D center and future U.K. headquarters in London, Merck is not only bailing on the project but is discontinuing all of its research operations in Britain, citing an unwelcoming business environment for drugmakers.

One week after warning that the United Kingdom is undervaluing life sciences manufacturing investments, trade organization the Association of the British Pharmaceutical Industry has issued another call to action for policymakers and the local biopharma scene.

Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space. The post Kriya Therapeutics has raised over $1.2 billion, but for what?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

From now on, MEI Pharma—previously best known for its clinical-stage leukemia drug—will be called Lite Strategy.

PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.

The Trump administration is considering putting “severe restrictions” on the increasing flow of investigational drugs from China, according to reporting by The New York Times.

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin marriages. The post When rare diseases are not so rare after all: A closer look at where and why this happens appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Odyssey Therapeutics’ team of seasoned drug developers is welcoming another impressive fundraising round, closing a $213 million series D round after abandoning plans to go public this summer.

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules. The post Top biotech deals in August 2025  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Capricor Therapeutics has publicly released its July response to the FDA's rejection of its Duchenne muscular dystrophy cell therapy deramiocel after the agency included deramiocel in a new batch of complete response letters released Sept. 4.

Pfizer veteran Suneet Varma has found his next role. Months after leaving the Big Pharma, Varma has taken the CEO position at the newly created inflammation and immunology startup Intent Biologics.

Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems. The post Advanced expression vector design to overcome challenges in developing multichain biotherapeutics appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a new AI platform.

Novartis is paying $1.4 billion to get its hands on Tourmaline Bio and its former Pfizer cardiovascular drug that impressed in a phase 2 study earlier this year.

The CNS-focused company is looking to pull off the first biotech IPO since February and collect $228.5 million in much-needed funding for further clinical development of its schizophrenia candidate.

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency could change. The post With Lykos CRL now public, FDA opens new era of accountability  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

After previously delaying its decision date, the FDA has outright rejected Saol Therapeutics’ investigational treatment for an ultrarare pediatric mitochondrial disease.

Regeneron’s allergen-blocking antibodies have reduced the symptoms of cat and pollen allergies in a pair of phase 3 studies.

Dianthus Therapeutics is advancing its challenge for the increasingly competitive generalized myasthenia gravis (gMG) market, outlining plans to move into phase 3 on the back of hits in a midphase study.

BioNTech and its new partner Bristol Myers Squibb have trotted out the first global data for their PD-L1xVEGF bispecific in small cell lung cancer. BioNTech’s chief medical officer, Özlem Türeci, M.D., described the findings as “very consistent” with the drug’s previous encouraging results from China.

Germ-free egg-based vaccines could be the answer to curbing yellow fever outbreaks. The post Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Our guests Alice Harrison and Megan Mason from Lonza discuss how the company is helping innovators develop and scale their therapies. The post Navigating the biotech development journey from first steps to global scale with Lonza appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company of the field. The post Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria. The post How are biotechs tackling malaria?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025. The post The biggest biotech funding rounds in August 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source

The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source

Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source

The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source

Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source

Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source

Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source

The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source

Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source

The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source

Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source

Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source

Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source

Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source

The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source

Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source

Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source

The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source

The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.

As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.